Approval · Notice of Compliance 26506 · 2021
HYDROXYCHLOROQUINE: Notice of Compliance 26506
Issued August 26, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26506
- Date
- August 26, 2021
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement Between Two Companies
- Canadian reference product
- PLAQUENIL (Sanofi-Aventis Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HYDROXYCHLOROQUINE | 02519348 | Marketed |
Medicinal ingredients
- HYDROXYCHLOROQUINE SULFATE 200 MG per TAB